What should you know about tofacitinib for ankylosing spondylitis?

Tofacitinib for ankylosing spondylitis requires specialist assessment because benefits, alternatives, interactions, and safety monitoring vary between patients. It changes signals involved in immune activity and is taken only as prescribed. Your rheumatologist will consider the pattern of spinal symptoms, other joints, previous medicines, infections, and your general health before recommending a treatment plan.

Ankylosing spondylitis can cause inflammatory back pain, joint stiffness, and reduced movement. Medicine aims to control inflammation and preserve function, while exercise and physiotherapy help maintain mobility. Tofacitinib may not be suitable for everyone, and it should not be started, stopped, or combined with another immune-modifying treatment without medical advice. Tell the prescriber about infections, vaccinations, liver or kidney problems, blood disorders, pregnancy plans, and every medicine or supplement you take.

Take doses exactly as directed and attend requested blood tests and reviews. Report signs of infection, such as fever, persistent cough, painful urination, or unusual fatigue. Keep an agreed movement programme, because medication and daily mobility work address different parts of care. Your clinician may discuss anti-inflammatory medication, exercise therapy, hydrotherapy, or physiotherapy as complementary or alternative approaches.

Contact your healthcare team promptly for a new infection, unexplained bruising, severe abdominal symptoms, or a significant change in your condition. Seek urgent help for chest pain, sudden breathlessness, coughing blood, one-sided leg swelling, facial swelling, or a severe allergic reaction.

Ask why tofacitinib is being considered, what alternatives exist, which tests are needed, when improvement will be reviewed, and what to do if you miss a dose or develop an infection.